Article
Slow-responders to IV beta2-adrenergic agonist therapy: defining a novel phenotype in pediatric asthma.
Pediatric pulmonology - 1 Jul 2008
Carroll Christopher L, Schramm Craig M, Zucker Aaron R
Abstract excerpt
OBJECTIVES: While aerosolized administration of beta(2)-adrenergic receptor (beta(2)-AR) agonists is the mainstay of treatment for pediatric asthma exacerbations, the efficacy of intravenous (IV) delivery is controversial. Failure to demonstrate improved outcomes with IV beta(2)-AR agonists may be due to phenotypic differences within this patient population. Our hypothesis is that children who respond more slowly...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.